You can receive independent, expert advice on alcohol treatment and alcohol rehab centres by telephoning DryOutNow.com on 0845 370 0203

The most important consideration in choosing the type of treatment for alcohol addiction is to match the individual to the alcohol treatment that is most likely to lead to a successful outcome.

DryOutNow.com can provide an assessment of all your needs and a recommendation regarding the most effective alcohol treatment for you, given your particular circumstances. We can provide fast, immediate access to alcohol treatment.

Avigen, Inc. (Nasdaq: AVGN), a biopharmaceutical company innovating therapeutics for neurological care, recently announced the launch of an exploratory study of the company's pipeline product, AV411 (ibudilast), for the treatment of opioid withdrawal symptoms. The study is largely funded by the National Institute on Drug Abuse (NIDA) and will be run jointly by the New York State Psychiatric Institute (NYSPI) and Columbia University.

"We are excited to participate in a study of this stature in partnership with NIDA, NYSPI and Columbia," said Kenneth Chahine, Ph.D., J.D., Avigen's President and Chief Executive Officer. "This trial builds upon our research of AV411's unique glial-attenuating properties and will complement Avigen's clinical studies of AV411 to treat neuropathic pain. We believe both of these exploratory paths may show that AV411 can become a breakthrough therapy for these disabling disorders."

"NIDA has chosen to fund this study based on its review of Avigen's research and its interest in the role of glial-attenuation as a novel way to treat opioid withdrawal symptoms, a common result of opioid abuse that can hinder recovery," said Frank J. Vocci, Ph.D., Director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse at the National Institute on Drug Abuse (NIDA). "This is truly an unmet medical need in this country. The nonmedical use or abuse of prescription drugs - primarily opioids - is a serious and growing public health problem. In fact, an estimated 33 million people have used prescription drugs for nonmedical reasons in their lifetimes - approximately 15 percent of the U.S. adult population."

The clinical study will assess the safety and tolerability of AV411, a non-opioid compound, when administered twice daily to heroin addicts who are maintained on morphine, a commonly used opiate analgesic drug, over a 14-day period. The trial will assess preliminary efficacy of AV411 for reducing the symptoms of opioid withdrawal.

"In preclinical studies, opioid treatment induces brain glial cell activation that correlates with both opioid tolerance and dependence," explained the study's principle investigator, Sandra D. Comer, Ph.D., Associate Professor of Clinical Neurobiology at NYSPI and Columbia University. "Preclinical studies have shown that AV411 can attenuate the behavioral signs of opioid withdrawal and corresponding glial cell activation without conferring adverse side effects. My research team and our partners are eager to confirm these findings in humans and help move this potentially important new medicine through clinical development."

Article published on 29/10/2008 by DryOutNow.com

DryOutNow.com provides highly practical help for people with alcohol problems, their friends and relatives. DryOutNow.com also provides free resources for healthcare professionals such as medical information and alcohol treatment guidelines.

• National rates of co-occurring substance use and mental disorders call for better integration of men ...... read
• Study will seek to break cycle of chemical dependence and incarceration ...... read
• Resolving to break an addiction - Help from Harvard Medical School ...... read
• Casual smokers have a greater risk of hazardous drinking and alcohol-use disorders ...... read
• Peptide ghrelin may be involved in both alcohol dependence and overeating ...... read
• Novel compound shows promise for treatment of alcoholism ...... read
• Potential new drug for cocaine addiction and overdose - Journal of the American Chemical Society ...... read
• Toward a fast, life-saving test for identifying the purity of heroin - Analytical Chemistry Journal ...... read
• Culture shapes young people s drinking habits ...... read
• Insomnia in adolescence linked to depression and substance abuse during adolescence and young adults ...... read
• ADHD stimulant treatment may decrease risk of substance abuse in adolescent girls ...... read
• Cocaine addicts display a thinner cortex which may reflect drug use and a pre-existing disposition ...... read
• Resveratrol prevents fat accumulation in livers of alcoholic mice ...... read
• Understanding why methamphetamine is so addictive ...... read
• Top researchers to explore stress and anxiety, trauma, poverty and addiction seminar ...... read
• Avigen initiates opioid withdrawal trial ...... read
• Federal anti-drug ad campaign may have had adverse effects ...... read
• Early adolescence is a sensitive time for exposure to alcohol and drugs ...... read
• Gene mutation key to alcohol tolerance in worm model ...... read
• Could brain abnormality predict drug addiction? ...... read

• Make Scotlands roads safer - reduce drink driving limits, says BMA Scotland ...... read
• Study will seek to break cycle of chemical dependence and incarceration ...... read
• More advice on alcohol and healthy living from UK Department of Health ...... read
• Working towards recovery, Getting problem drug users into jobs: UKDPC report released ...... read
• More support needed for employers to hire addicts, says research ...... read